Jim Cramer: Kimberly-Clark's Kenvue Buy Creates High-Margin Powerhouse

On Tuesday's episode of CNBC's Mad Money, Jim Cramer highlighted Kimberly-Clark Corporation (NYSE:KMB) as a defensive holding for investors looking to lock in profits from high-flying technology stocks and reallocate into lower-risk value plays. After years of sluggish price action, Cramer noted that the consumer giant has finally established a stable bottom, anchored by its acquisition of Kenvue from Johnson & Johnson.

Recommendation Change

Cramer did not formally change his rating, but he emphasized KMB as an attractive defensive opportunity. The stock is trading near its bottom, making it suitable for risk-averse investors.

Analyst's Rationale

Cramer believes the Kenvue acquisition creates a "high-margin powerhouse" combining strong brands in personal care and hygiene. The deal enhances Kimberly-Clark's position in consumer healthcare, offering cost synergies and scale. Additionally, the stock's solid dividend yield makes it appealing in a low-interest-rate environment.

Context

Kimberly-Clark announced the acquisition of Kenvue for approximately $12 billion in May 2026, aiming to expand its healthcare portfolio. Other analysts are divided; some see value creation, while others question integration risks. KMB shares have risen about 8% since the announcement but remain below their 200-day moving average.

What to Make of It

Cramer's call reflects a cautiously optimistic view on Kimberly-Clark post-acquisition. Investors should monitor Kenvue's integration and its impact on margins and cash flows. The stock suits defensive investors but may not deliver rapid short-term gains.